Raising the level of Factor I above physiological levels can be used to treatdiseases in which the underlyingpathology is linked to overactivity of the C3b-feedback cycle and thegeneration and pro-inflammatory effects of iC3b. Methods,agents, and compositions for treatment of such diseases are described.